Status:

UNKNOWN

Influence of EPICardial Adipose Tissue in HEART Diseases: EPICHEART Study

Lead Sponsor:

Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.

Collaborating Sponsors:

Universidade do Porto

Conditions:

Coronary Artery Disease

Coronary Arteriosclerosis

Eligibility:

All Genders

18+ years

Brief Summary

This translational study was designed to explore the association of the quantity and quality of epicardial adipose tissue (EAT) with coronary artery disease (CAD), left atrial remodeling and postopera...

Detailed Description

Background: EAT has emerged as a new independent, and, potentially, modifiable cardiovascular risk factor for CAD. EAT volume assessed by computed tomography (CT) was independently associated with the...

Eligibility Criteria

Inclusion

  • symptomatic severe aortic stenosis patients (defined as aortic valve area of \< 1 cm2 or 0.6 cm2/m2 by transthoracic echocardiography) referred to aortic valve replacement.

Exclusion

  • diagnosis of acute coronary syndrome in the last 3 months.
  • prior history of persistent or permanent atrial or flutter fibrillation.
  • coexisting moderate to severe aortic valve regurgitation or moderate to severe mitral valve disease, bicuspid aortic valve.
  • left ventricular dilatation \[end-diastolic volume index \>75 mL/m²\].
  • left ventricular ejection fraction \<55%.
  • chronic renal failure stage 3 to 5 defined as glomerular filtration rate GFR estimated by Cockcroft-Gault formula adjusted for body surface area \< 30 mL/min/1.73m².
  • moderate to severe chronic obstructive pulmonary disease defined as forced expiratory volume in one second \<50% according to the 2011 Global Initiative for Chronic Obstructive Pulmonary Disease guidelines.
  • active malignancy (i.e. With no evidence of recurrence and no longer receiving active treatment).

Key Trial Info

Start Date :

September 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 25 2018

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT03280433

Start Date

September 1 2014

End Date

November 25 2018

Last Update

September 14 2017

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Centro Hospitalar de Vila Nova de Gaia/Espinho

Vila Nova de Gaia, Porto District, Portugal, 4430-502

2

Faculty of Medicine of Porto

Porto, Portugal, 4200-319